Mesh Stents Study in ILIAC Complex Lesions (IMS-Study)

Inclusion Criteria: * General Inclusion Criteria (principal): * Patients older than 18 years, after Vascular Team evaluation, according to local standards, eligible for Iliac artery * Written, informed consent to participate * Agreement to attend Protocol required (standard) follow up visits and examinations * Angiographic Inclusion Criteria (principal): * De novo iliac stenosis * Stenosis eligible for endovascular treatment per Vascular Team evaluation (according to current standards and guidelines) * High-risk morphology stenosis with complex/thrombotic lesions (per 1 independent, experienced operator). Exclusion Criteria: * General Exclusion Criteria (principal): * Life expectancy \<1 year (e.g., active neoplastic disease). * Chronic kidney disease with creatinine \> 3.0 mg/dL. * Coagulopathy. * Contraindication for decoagulation * History of uncontrolled contrast media intolerance * Myocardial infarction in 72 hours preceding the stenting procedure (if possible, postponing the procedure) * Stroke in 6 weeks preceding the stenting procedure (if possible, postponing the procedure) * Pregnancy (positive pregnancy test) * AngiographicExclusion Criteria (principal): * Chronic total occlusion not amenable to re-canalization * Stent in the target vessel/lesion * Anatomic variants precluding stent implantation * Mobile (free-floating) plaque elements in aorta or arteries proximal to the target lesion